BDBM50148001 2-Guanidino-4-methyl-pentanoic acid (2-{4-[5-(2,3-dichloro-4-methoxy-phenyl)-2-methyl-2H-pyrazol-3-yl]-piperidin-1-yl}-2-oxo-ethyl)-amide::CHEMBL421412

SMILES [#6]-[#8]-c1ccc(-c2cc(-[#6]-3-[#6]-[#6]-[#7](-[#6]-[#6]-3)-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@@H](-[#6]-[#6](-[#6])-[#6])\[#7]=[#6](/[#7])-[#7])n(-[#6])n2)c(Cl)c1Cl

InChI Key InChIKey=ZYZXWXSXYXITMA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50148001   

TargetInterleukin-2 receptor subunit alpha(Mouse)
Sunesis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50148001(2-Guanidino-4-methyl-pentanoic acid (2-{4-[5-(2,3-...)
Affinity DataIC50: 3.50E+3nMAssay Description:Concentration required to inhibit mouse interleukin-2 alpha receptor was determined by SPA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/30/2012
Entry Details Article
PubMed